Stock Events

Stock Events

Avalo Therapeutics (C6K0.F) Q4 2024 Earnings

7NovConfirmed

Q2 2024

Q3 2024

Q4 2024

-130.63

-87.45

-44.27

-1.09

Details

Expected EPS

-1.1017139

Actual EPS

-2.6200423

Surprise EPS

-1.52

Surprise Percent

+137.82%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -2.6200423 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.